2023 was a troublesome 12 months with the biopharma market, with quite a few organizations downsizing and restructuring their workforces to stay afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and existence sciences sector from the latter Element of 2023 and possess ongoing https://sites.google.com/view/bio-sites/blog